Erectile Dysfunction Clinical Trial
Official title:
A Multi-Center Study to Assess the AMS IPP 2005 Inflatable Penile Prosthesis Cylinders, Pump and Reservoir.
NCT number | NCT00636506 |
Other study ID # | AMS052 |
Secondary ID | |
Status | Completed |
Phase | Phase 2 |
First received | |
Last updated | |
Start date | August 2005 |
Est. completion date | January 2008 |
Verified date | May 2019 |
Source | American Medical Systems |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to evaluate modifications to the AMS 700 Series pump, cylinders, reservoir and rear tip extender design, their impact on ease of use for the patient, and ease of implantation for the physician.
Status | Completed |
Enrollment | 76 |
Est. completion date | January 2008 |
Est. primary completion date | February 2006 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 21 Years and older |
Eligibility |
1. Inclusion Criteria To be eligible to participate in this study, male subjects must meet the following requirements: 1. The subject has been diagnosed with erectile dysfunction and has made an informed decision to be implanted with the AMS IPP 2005 Inflatable Penile Prosthesis Cylinder, Pump, and Reservoir. 2. The subject has not had a previous penile prosthesis. 3. The subject is willing and able to give written valid Informed Consent. 4. The subject's reading level is judged adequate for reading and understanding the Informed Consent, patient questionnaires, and other study material 5. The subject is = 21 years of age. 6. The subject has no known sensitivity to rifampin, minocycline or other tetracyclines as indicated in the device labeling. 7. The subject does not have systemic lupus erythematosus 8. The subject has the manual dexterity or mental ability to operate the pump. 9. The subject does not have active urogenital infection or active skin infection in region of surgery as indicated in the device labeling. 10. The subject is willing and able to return for follow-up evaluations and questionnaire completion according to the study protocol. 11. The subject is an acceptable risk for anesthesia and surgery. 2. Exclusion Criteria Subjects will not be eligible for entry into this study if they meet any of the following criteria: 1. The subject's reading level is judged inadequate for reading and understanding the Informed Consent, patient questionnaires, and other study materials. 2. The subject is not willing or able to give written valid Informed Consent 3. The subject meets any of the following contraindications for InhibiZone™ use: i. known allergy to or sensitivity to rifampin, minocycline, or to tetracyclines. ii. diagnosed with systemic lupus erythematosus. d) The subject has a current Urinary Tract Infection (UTI), urogenital infection, or active skin infection in the region of surgery. e) The subject does not have the manual dexterity or mental ability to operate the pump. f) The subject has a compromised immune system. g) The subject refuses to, or is unable to, comply with the requirements of the protocol or return for follow-up visits. h) The subject has been diagnosed with severe fibrosis due to priapism. |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan School of Medicine | Ann Arbor | Michigan |
United States | New York Center for Human Sexuality | Brooklyn | New York |
United States | Institute for Urologic Excellence | Indio | California |
United States | Medical Research Associates of Nashville | Nashville | Tennessee |
United States | Advanced Research Institute | New Port Richey | Florida |
United States | University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma |
United States | Regional Urology, LLC | Shreveport | Louisiana |
Lead Sponsor | Collaborator |
---|---|
American Medical Systems |
United States,
Knoll LD, Henry G, Culkin D, Ohl DA, Otheguy J, Shabsigh R, Wilson SK, Delk Ii J. Physician and patient satisfaction with the new AMS 700 momentary squeeze inflatable penile prosthesis. J Sex Med. 2009 Jun;6(6):1773-1778. doi: 10.1111/j.1743-6109.2009.012 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ease of Locating the Inflation Pump Bulb | Physicians were asked to observe patients manipulating the device and to answer the question: "Could the subject easily locate the inflation pump bulb?" The response options were: Yes, No, and Not Tested | 4-8 weeks | |
Primary | Ease of Pumping Device to Full Erection | Physicians were asked, "Compared to current AMS 700 pumps, please rate the ease of the inflation relating to the downward orientation of the AMS IPP 2005 pump bulb". Response options were on a 5-point Likert scale - Much easier; Somewhat easier; Same; Somewhat harder; Much harder. | 4-8 weeks post-op | |
Primary | Quality of Erection (Suitability for Intercourse) | Physicians were asked: "After inflation, did the erection appear suitable for sexual intercourse?" Response options were: Yes, No, Not Assessed | 4-8 weeks, 3 months, 6 months | |
Primary | Subjective Force Required to Inflate Device | At the 3 and 6 month visit, subjects were asked to assess the force required to initiate inflation of the device. Response options were "Reasonable" and "Too Much" | 3 months, 6 months | |
Primary | Ability to Inflate Device Using One Hand | Subjects were asked if they were able to inflate the device using one hand. Response options were: Yes, No | 3 months, 6 months | |
Primary | Ease of Training Patient to Inflate Device Compared to the AMS Tactile Pump | Physicians were asked: "Please rate the ease of training the subject to use the new AMS IPP 2005 pump in comparison to the AMS tactile pump." Response options were: Much easier, Somewhat easier, Same, Somewhat harder, Much harder | 4-8 weeks follow-up | |
Primary | Ease of Training Patient to Inflate Device Compared to the Standard AMS 700 Pump | Physicians were asked: "Please rate the ease of training the subject to use the new AMS IPP 2005 pump in comparison to the standard AMS 700 pump." Response options were: Much easier, Somewhat easier, Same, Somewhat harder, Much harder | 4-8 week activation visit | |
Primary | Time to Complete Inflation | Physicians were asked: "How much time was required for the subject to inflate?" Response options were: 0-30 seconds, 30-60 seconds, 60-90 seconds, 90-120 seconds, 2-3 minutes, Over 3 minutes | 4-8 week activation visit | |
Primary | Ease of Locating the Deflation Block | Physicians were asked: "Could the deflation button be easily located?" Response options were: Yes, No, and Not Tested | 4-8 week activation visit | |
Primary | Subjective Force Required to Initiate Deflation | Subjects were asked: "The force required to initiate deflation was..." The response options were: "Too Much" and "Reasonable amount". | 3 months, 6 months | |
Primary | Ability to Deflate Cylinders by Pressing the Deflation Button for Only a Few Seconds | Physicians were asked to assess: "How long did you have to hold the deflation button for the deflation to set in motion?" The response options were: 1-2 seconds; 3-4 seconds; 5-6 seconds; 7-8 seconds; 9-10 seconds; More than 10 seconds, specify seconds. | 3 months, 6 months | |
Primary | Time to Complete Deflation | Physicians were asked to assess: "How much time did it take for the device to deflate?" The response options were: 5-6 seconds; 7-8 seconds; 9-10 seconds; 10-15 seconds; 15-20 seconds; 20-25 seconds; 25-30 seconds; 35-40 seconds; 40-45 seconds; 45-50 seconds; More than 50 seconds, specify # of seconds | 3 months, 6 months | |
Primary | Ability to Deflate Device With One Hand | "Could the subject easily deflate the AMS IPP 2005 with one hand?" The response options were: Yes; No; and Not Tested. | 3 months, 6 months | |
Primary | Level of Flaccidity Achieved | Physicians were asked "How would you rate the flaccidity of the AMS IPP 2005 cylinders at full deflation?" Response options were: Excellent; Very good; Good; Fair; Poor. | 4-8 weeks | |
Primary | Ease of Training Patient to Deflate Device | Physicians were asked to assess: "Please rate the ease of training the subject to use the new AMS IPP 2005 pump in comparison to the AMS Tactile Pump." The response options were: Much easier; Somewhat easier; Same; Somewhat harder; Much harder | 4-8 weeks | |
Primary | Patient Satisfaction With Deflation Mechanism | Subjects were asked to assess: "Satisfaction with softness of penis when prosthesis is flaccid." Response options were: Very satisfied; Moderately satisfied; Somewhat satisfied; Somewhat dissatisfied; Moderately dissatisfied; Very dissatisfied | 3 Months, 6 Months | |
Primary | Ease of Dilation With the Reduced Angle of the Input Tubing | Physicians were asked: "As compared to other devices, did the angle of the input tubing make it easier to insert?" Response options were: Yes; No/No effect | Time of implant (surgery) | |
Primary | Ease of Cylinder Placement With the Enhanced Profile of the Proximal Tip | Physicians were asked: "How would you rate the overall ease of proximal insertion of the AMS IPP 2005 cylinders?" Response options were: Very easy; Moderately easy; Neither easy nor difficult; Moderately difficult; Very difficult | For duration of surgery | |
Primary | Comparison With Other Devices for Ease of Placement | Physicians were asked: "Compared to other cylinders you have used, how would you rate the ease of proximal insertion of the AMS IPP 2005 cylinders?" Response options were: Much easier; Slightly easier; Same; Somewhat more difficult; More difficult | For duration of surgery | |
Primary | Rating of the Rigidity of the Cylinders | Physicians were asked: "How would you rate the rigidity of the AMS IPP 2005 cylinders at full inflation?" Response options were: Excellent; Very good; Good; Fair; Poor | 4-8 weeks follow-up | |
Primary | Ease of Insertion of New Flare Design Reservoir | Physicians were asked: "As compared to the current 700 reservoir, how would you rate the ease of insertion of the AMS IPP 2005 reservoir?" Response options were: Much easier; Somewhat easier; Same; Somewhat harder; Much harder | For duration of surgery | |
Primary | Ability of New Flare Design to Remain in Place | Physicians were asked: "As comparable to the previous AMS 700 reservoir, does the new flare design of the AMS IPP 2005 reservoir retain its position as implanted?" Response options were: Yes; No | For duration of surgery | |
Primary | Ease Attaching the New Snap Design Rear Tip Extender (RTE) to the Proximal Tip of the Cylinder | Physicians were asked to assess their satisfaction level with the new snap design rear tip extender. Answer options were: Very satisfied; Moderate satisfied; Neutral; Moderately dissatisfied; Very dissatisfied. | For duration of surgery | |
Primary | Comparison Rating of the New Rear Tip Extender Design to Previous Design | Physicians were asked, "Compared to AMS 700 RTE and other stackable RTE configurations, how would you rate the AMS IPP 2005 RTE configuration?" Answer options were: No RTEs implanted; Much better; Somewhat better; Same; Somewhat worse; Much worse | For duration of surgery | |
Primary | Physician Evaluation of the Pre-threaded Suture Needle for Ease of Removing Sheath | Physicians were asked, "Was it easy to remove the blue suture sheath and white needle holder?" Answer options were: Yes; No, please explain | For duration of surgery | |
Primary | Physician Evaluation of the Pre-threaded Suture Needle for Ease of Loading Furlow Tool | Physicians were asked to assess the overall design compared to the current non-threaded design. Answer options: Significantly better; Better; Same; Worse; Significantly worse | For duration of surgery | |
Primary | Physician Evaluation of OR Device Preparation Time | Physicians were asked if the design of the pre-threaded needle facilitated faster loading of the Furlow tool. Answer options were: Yes; No | For duration of surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05366504 -
LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment
|
Phase 2/Phase 3 | |
Recruiting |
NCT02745808 -
Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes
|
Phase 1 | |
Recruiting |
NCT02573805 -
the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males
|
N/A | |
Withdrawn |
NCT02579148 -
Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes
|
Phase 1 | |
Withdrawn |
NCT01967251 -
Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction
|
Phase 2 | |
Recruiting |
NCT02225548 -
Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
|
Phase 4 | |
Completed |
NCT02587988 -
Trial to Evaluate the Efficacy and Safety of HCP1302
|
Phase 3 | |
Completed |
NCT01937871 -
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)
|
Phase 3 | |
Completed |
NCT02945462 -
Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED)
|
Phase 1 | |
Completed |
NCT01698684 -
Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction
|
Phase 4 | |
Not yet recruiting |
NCT01321489 -
A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies
|
Phase 3 | |
Terminated |
NCT01262833 -
Pudendal Assessment in Erectile Dysfunction
|
N/A | |
Completed |
NCT01230541 -
Effect of Udenafil on Spermatogenesis
|
Phase 1 | |
Completed |
NCT02226237 -
Effectiveness of Physiotherapy to Treat the Urinary Incontinence and Erectile Dysfunction Post Retropubic Prostatectomy
|
N/A | |
Completed |
NCT01037244 -
Treatment of Erectile Dysfunction I
|
Phase 3 | |
Completed |
NCT01037218 -
Treatment of Erectile Dysfunction II
|
Phase 3 | |
Recruiting |
NCT00313898 -
Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning Males
|
Phase 4 | |
Completed |
NCT00421083 -
Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury
|
Phase 3 | |
Completed |
NCT00663728 -
Assessment of Duration of Erection With Vardenafil 10 mg
|
Phase 4 | |
Completed |
NCT00667979 -
Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse
|
Phase 4 |